Shanshan Song
Jiangxi University of Traditional Chinese Medicine(CN)Jiangnan University(CN)Johns Hopkins University(US)Harbin Engineering University(CN)Henan University(CN)Chinese Academy of Sciences(CN)University of California System(US)University of California San Diego(US)Institute for Biodiversity(DE)Shanghai Institute of Materia Medica(CN)Baotou Central Hospital(CN)State Key Laboratory of Food Science and Technology(CN)Fourth Hospital of Inner Mongolia(CN)Chengdu Technological UniversityQingdao University of Technology(CN)Hanyang University(KR)Kansai University(JP)
Publications by Year
Research Areas
Pulmonary Hypertension Research and Treatments, Natural Compounds in Disease Treatment, Nanoparticle-Based Drug Delivery, PARP inhibition in cancer therapy, Glioma Diagnosis and Treatment
Most-Cited Works
- → Endothelial HIF-2α Contributes to Severe Pulmonary Hypertension by Inducing Endothelial-to-Mesenchymal Transition(2017)178 cited
- → A SERS-active sensor based on heterogeneous gold nanostar core–silver nanoparticle satellite assemblies for ultrasensitive detection of aflatoxinB1(2015)160 cited
- → Can Social Policies Improve Health? A Systematic Review and Meta‐Analysis of 38 Randomized Trials(2020)121 cited
- → Upregulated expression of STIM2, TRPC6, and Orai2 contributes to the transition of pulmonary arterial smooth muscle cells from a contractile to proliferative phenotype(2015)118 cited
- → HIT-COVID, a global database tracking public health interventions to COVID-19(2020)114 cited
- → Notch Activation of Ca2+ Signaling in the Development of Hypoxic Pulmonary Vasoconstriction and Pulmonary Hypertension(2015)98 cited